HKEX green-lights the listing of pre-revenue Biotech companies and companies with weighted voting rights structure

HKEX published New Board Concept Paper Consultation Conclusions on 15 December 2017, and has decided to abandon its earlier plan of setting up a New Board. It will indeed facilitate the listing of the new economy companies through two new chapters in the Main Board Listing Rules for (a) pre-revenue Biotech companies; and (b) innovative and high growth companies with Weighted Voting Rights structure.